Er-Kim Extends Exclusive Distribution Agreement with Ascendis Pharma AS to Expand Commercialization of Its Endocrinology Portfolio to Eurasian Markets
ASND Stock | USD 140.31 1.52 1.10% |
About 58% of all Ascendis Pharma's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Ascendis Pharma AS suggests that some traders are interested. The current market sentiment, together with Ascendis Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Ascendis Pharma AS stock news signals to limit their universe of possible portfolio assets.
Ascendis |
Broadened agreement now addresses the unmet need for novel rare endocrinology disease therapies in Central and Eastern Europe and Eurasian marketsATHENS, Greece and ALMATY, Kazakhstan, Dec. 10, 2024 -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced that it has extended its exclusive agreement with Danish biopharmaceutical company Ascendis Pharma AS to commercialize three rare endocrinology
Read at finance.yahoo.com
Ascendis Pharma Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Ascendis Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ascendis Pharma Fundamental Analysis
We analyze Ascendis Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ascendis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ascendis Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Ascendis Pharma is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Ascendis Pharma AS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ascendis Pharma stock to make a market-neutral strategy. Peer analysis of Ascendis Pharma could also be used in its relative valuation, which is a method of valuing Ascendis Pharma by comparing valuation metrics with similar companies.
Peers
Ascendis Pharma Related Equities
PLRX | Pliant Therapeutics | 4.00 | ||||
REPL | Replimune | 2.32 | ||||
ACLX | Arcellx | 1.86 | ||||
DAWN | Day One | 1.82 | ||||
BGNE | BeiGene | 1.68 | ||||
BPMC | Blueprint Medicines | 1.28 | ||||
AKRO | Akero Therapeutics | 1.16 | ||||
UTHR | United Therapeutics | 0.90 | ||||
ETNB | 89bio | 0.88 | ||||
MDGL | Madrigal Pharmaceuticals | 0.65 | ||||
CRNX | Crinetics Pharmaceuticals | 0.04 | ||||
NUVL | Nuvalent | 0.71 | ||||
APLS | Apellis Pharmaceuticals | 1.08 | ||||
AMLX | Amylyx Pharmaceuticals | 1.72 | ||||
STOK | Stoke Therapeutics | 2.50 | ||||
VTYX | Ventyx Biosciences | 3.40 |
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |